| Halper Sadeh LLC Encourages EXAS, NVRI, MRUS Shareholders to Contact the Firm to Discuss Their Rights |
Globe Newswire |
11/22 |
06:25 |
| AP Copilot to Host Official Launch Celebration |
Globe Newswire |
11/20 |
13:23 |
| Crunchafi and Fieldguide Partner to Redefine Audit Efficiency |
Globe Newswire |
11/19 |
09:00 |
| Ascentage Pharma to Participate in Three Upcoming Investor Conferences in December 2025 |
Globe Newswire |
11/19 |
08:00 |
| GS E&C Strengthens Partnership with Amogy Through Strategic Investment to Accelerate Carbon-Free Distributed Power Innovation |
Globe Newswire |
11/17 |
08:00 |
| ACM Research Delivers First Horizontal Panel Electroplating Tool Strengthening Its Leadership in Fan-Out Panel-Level Packaging |
Globe Newswire |
11/16 |
19:00 |
| McGraw Milhaven to Host Nationally Syndicated America at Night |
Globe Newswire |
11/14 |
11:00 |
| Flow Cytometry Services Market Envisions USD 8.39 Billion by 2034, Growing at a 9.77% CAGR |
Globe Newswire |
11/14 |
08:00 |
| Global Active Implantable Medical Devices Market Set to Reach New Heights at a CAGR of ~7% by 2032, Driven by Rising Chronic Disease Burden and Technological Advancements | DelveInsight |
Globe Newswire |
11/13 |
13:00 |
| Shots Podcast Network Joins Cumulus Podcast Network, Bringing Unfiltered Entertainment to Millions of Listeners |
Globe Newswire |
11/12 |
14:44 |
| Collaboration with Freestar Expands Access to Premium Advertisers for The Associated Press |
Globe Newswire |
11/12 |
09:00 |
| Fortinet Secure LAN Edge Delivered 308% ROI and 50% Higher NetOps Efficiency |
Globe Newswire |
11/12 |
09:00 |
| Amogy and Samsung Heavy Industries Sign Strategic Partnership for Manufacturing of Amogy's Ammonia-to-Power Systems |
Globe Newswire |
11/12 |
08:00 |
| AmpliTech Group, Inc. Unit Rights Offering Subscription Period Begins November 11, 2025 |
Globe Newswire |
11/11 |
07:00 |
| ADARx Pharmaceuticals Announces Positive Interim Phase 1 Clinical Data for its Novel siRNA Targeting Complement Factor B (CFB) |
Globe Newswire |
11/07 |
11:00 |
| Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide |
Globe Newswire |
11/07 |
08:45 |
| ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2025 |
Globe Newswire |
11/07 |
08:00 |
| Chris Van Vliet Joins Cumulus Podcast Network |
Globe Newswire |
11/06 |
14:00 |
| Just One Week Away! HMG Strategy’s Annual New York Global Innovation Summit 2025 unites CIOs, CISOs, and top executives to share insight on IT, AI, cyber security, and innovation |
Globe Newswire |
11/06 |
10:56 |
| New Study Reveals the “New Normal” in Finance: Economic Pressures Push Middle Market Teams Toward Faster Digital and AI |
Globe Newswire |
11/06 |
10:00 |
| KMX Investor Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against CarMax, Inc. |
Globe Newswire |
11/05 |
16:20 |
| NevGold Announces Up to 85% Antimony Recovery From Positive Phase II Metallurgical Testwork at Oxide Gold-Antimony Limo Butte Project in Nevada |
Globe Newswire |
11/05 |
07:00 |
| ORYZON Announces Positive Clinical Data of Iadademstat at ASH-2025 |
Globe Newswire |
11/04 |
08:00 |
| Ascentage Pharma to Present Data from Multiple Studies of Olverembatinib, Including the First Dataset from POLARIS-1 Study, at ASH 2025 |
Globe Newswire |
11/03 |
20:10 |
| Ascentage Pharma to Present Data from Two Clinical Studies for Bcl-2 Inhibitor Lisaftoclax, Including an Oral Report, at ASH 2025 |
Globe Newswire |
11/03 |
20:10 |
